(Q35015790)

5 August 2017

1 reference

title

Dopamine agonists and neuroprotection in Parkinson's disease (English)

1 reference

5 August 2017

0 references

1

A H V Schapira

1 reference

PubMed ID

12464116

5 August 2017

language of work or name

1 reference

1 November 2002

1 reference

European Journal of Neurology

5 August 2017

1 reference

5 August 2017

9 Suppl 3

1 reference

5 August 2017

7-14

1 reference

Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system

5 August 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.9.S3.9.X

Chronic systemic pesticide exposure reproduces features of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.9.S3.9.X

Increased vulnerability of dopaminergic neurons in MPTP-lesioned interleukin-6 deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.9.S3.9.X

Increased nigral iron content in postmortem parkinsonian brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.9.S3.9.X

Apomorphine is a highly potent free radical scavenger in rat brain mitochondrial fraction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.9.S3.9.X

Pergolide scavenges both hydroxyl and nitric oxide free radicals in vitro and inhibits lipid peroxidation in different regions of the rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.9.S3.9.X

A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.9.S3.9.X

Positron emission tomographic analysis of the nigrostriatal dopaminergic system in familial parkinsonism associated with mutations in the parkin gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.9.S3.9.X

Dopamine D2 receptor-mediated antioxidant and neuroprotective effects of ropinirole, a dopamine agonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.9.S3.9.X

An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.9.S3.9.X

Pharmacology of dopamine agonists in the treatment of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.9.S3.9.X

Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.9.S3.9.X

Association between early-onset Parkinson's disease and mutations in the parkin gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.9.S3.9.X

Oxygen toxicity protecting enzymes in Parkinson's disease. Increase of superoxide dismutase-like activity in the substantia nigra and basal nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.9.S3.9.X

Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.9.S3.9.X

Mapping of a gene for Parkinson's disease to chromosome 4q21-q23

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.9.S3.9.X

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.9.S3.9.X

A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.9.S3.9.X

Prevention of transneuronal degeneration of neurons in the substantia nigra reticulata by ablation of the subthalamic nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.9.S3.9.X

Science, medicine, and the future: Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.9.S3.9.X

Neuroprotection and dopamine agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.9.S3.9.X

Possible environmental, occupational, and other etiologic factors for Parkinson's disease: a case-control study in Germany.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.9.S3.9.X

Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.9.S3.9.X

Expression of mutant alpha-synuclein causes increased susceptibility to dopamine toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.9.S3.9.X

The role of environmental toxins in the etiology of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.9.S3.9.X

The dopamine agonist cabergoline provides neuroprotection by activation of the glutathione system and scavenging free radicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.9.S3.9.X

Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.9.S3.9.X

Neuroprotection by pramipexole against dopamine- and levodopa-induced cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.9.S3.9.X

PARK6-linked parkinsonism occurs in several European families.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.9.S3.9.X

Sequencing of the alpha-synuclein gene in a large series of cases of familial Parkinson's disease fails to reveal any further mutations. The European Consortium on Genetic Susceptibility in Parkinson's Disease (GSPD)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.9.S3.9.X

Failure to find the alpha-synuclein gene missense mutation (G209A) in 100 patients with younger onset Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.9.S3.9.X

The effect of pergolide and MDL 72974 on rat brain CuZn superoxide dismutase

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.9.S3.9.X

Reduction of lipid peroxidation in different rat brain areas after cabergoline treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.9.S3.9.X

Glial cells and inflammation in Parkinson's disease: a role in neurodegeneration?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.9.S3.9.X

Clinical analysis of 17 patients in 12 Japanese families with autosomal-recessive type juvenile parkinsonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.9.S3.9.X

Environmental risk factors in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.9.S3.9.X

Bromocriptine protects mice against 6-hydroxydopamine and scavenges hydroxyl free radicals in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.9.S3.9.X

Mutation, sequence analysis, and association studies of alpha-synuclein in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.9.S3.9.X

Will neurology residents with large student loan debts become academicians?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.9.S3.9.X

Iron-reducing and free-radical-scavenging properties of apomorphine and some related benzylisoquinolines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.9.S3.9.X

10.1046/J.1468-1331.9.S3.9.X

21 January 2018

Identifiers

DOI

1 reference

5 August 2017

1 reference

PubMed ID

12464116